title: Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?
authors.forename: Jost B
authors.initials: JB
authors.lastname: Jonas
authors.forename: Antje
authors.initials: A
authors.lastname: Söfker
authors.forename: Jochen
authors.initials: J
authors.lastname: Hayler
authors.forename: Robert F
authors.initials: RF
authors.lastname: Degenring
mesh_terms: D003131:Combined Modality Therapy; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014821:Vitrectomy; D018630:Vitreoretinopathy, Proliferative / Q000150:complications / Q000188:drug therapy* / Q000601:surgery*; D014822:Vitreous Body
chemical_list: D005938:Glucocorticoids; D014222:Triamcinolone Acetonide